Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.

CLYM

Climb Bio (CLYM)

Climb Bio Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:CLYM
DateHeureSourceTitreSymboleSociété
09/01/202513h00GlobeNewswire Inc.Climb Bio Expands Pipeline Through an Exclusive License to Develop and Commercialize an Antibody Targeting the APRIL Pathway for IgA NephropathyNASDAQ:CLYMClimb Bio Inc
19/12/202413h00GlobeNewswire Inc.Climb Bio to be Added to the Nasdaq Biotechnology IndexNASDAQ:CLYMClimb Bio Inc
12/11/202422h05GlobeNewswire Inc.Climb Bio Reports Third Quarter 2024 Financial Results and Business HighlightsNASDAQ:CLYMClimb Bio Inc
11/11/202413h00GlobeNewswire Inc.Climb Bio Appoints Douglas E. Williams, Ph.D., as Chair of the BoardNASDAQ:CLYMClimb Bio Inc
31/10/202412h00GlobeNewswire Inc.Climb Bio to Present at Upcoming Investor ConferencesNASDAQ:CLYMClimb Bio Inc
15/10/202413h00GlobeNewswire Inc.Climb Bio to Provide Budoprutug Development Strategy and Corporate Update at Virtual Investor EventNASDAQ:CLYMClimb Bio Inc
11/10/202418h30GlobeNewswire Inc.Climb Bio Announces Abstract Selected for Presentation at the American Society of Nephrology Kidney Week 2024NASDAQ:CLYMClimb Bio Inc
04/10/202413h00GlobeNewswire Inc.Climb Bio to Present at William Blair’s Upcoming Conference Event on Transforming Autoimmune Diseases by Targeting CD19NASDAQ:CLYMClimb Bio Inc
03/10/202416h00GlobeNewswire Inc.Climb Bio to Host Virtual Investor Event on October 15, 2024NASDAQ:CLYMClimb Bio Inc
 Showing the most relevant articles for your search:NASDAQ:CLYM